Finance

Beta
Lists
301263:SHE
Guangdong Taienkang Pharmaceut Co Ltd
CN¥25.31
-0.28%
(-0.070) 1D
May 29, 3:04:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301263...
Open
CN¥25.38
High
CN¥25.80
Low
CN¥24.65
Mkt. cap
10.77B
Avg. vol.
4.21M
Volume
4.66M
Dividend
0.20%
Quarterly dividend
CN¥0.01
Ex-dividend date
May 27, 2025
P/E ratio
419.53
52-wk high
CN¥42.26
52-wk low
CN¥24.60
EPS
CN¥0.06
Shares outstanding
425.50M
No. of employees
1K
Open
CN¥25.38
High
CN¥25.80
Low
CN¥24.65
Mkt. cap
10.77B
Avg. vol.
4.21M
Volume
4.66M
Dividend
0.20%
Quarterly dividend
CN¥0.01
Ex-dividend date
May 27, 2025
P/E ratio
419.53
52-wk high
CN¥42.26
52-wk low
CN¥24.60
EPS
CN¥0.06
Shares outstanding
425.50M
No. of employees
1K
News stories
From sources across the web
About Guangdong Taienkang Pharmaceut Co Ltd
CEO-
Employees1.15K
FoundedJan 22, 1999
Headquarters-
SectorPharmaceutical industry
Websitetai-kang.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
162.42M
178.75M
149.07M
189.52M
Cost of goods sold
88.99M
73.61M
84.18M
70.35M
Cost of revenue
88.99M
73.61M
84.18M
70.35M
Research and development expenses
19.05M
20.28M
23.44M
13.59M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
62.64M
89.57M
61.31M
70.73M
Operating expense
84.66M
109.71M
83.83M
85.13M
Total operating expenses
173.65M
183.32M
168.01M
155.47M
Operating income
-11.24M
-4.57M
-18.94M
34.04M
Other non operating income
541.67K
252.38K
-512.13K
-612.31K
EBT including unusual items
-11.00M
-7.07M
-27.84M
30.45M
EBT excluding unusual items
-12.39M
-7.16M
-22.67M
31.60M
Income tax expense
-12.22M
2.87M
-18.62M
5.53M
Effective tax rate
111.09%
-40.64%
66.87%
18.18%
Other operating expenses
2.12M
-1.09M
685.26K
816.63K
Net income
5.54M
-5.68M
-2.77M
28.58M
Net profit margin
3.41%
-3.18%
-1.86%
15.08%
Earnings per share
-
-
-
-
Interest and investment income
928.87K
-
3.23M
1.49M
Interest expense
-2.53M
-2.93M
-5.88M
-3.33M
Net interest expenses
-1.60M
-2.93M
-2.65M
-1.83M
Depreciation and amortization charges
-
-
-
-
EBITDA
4.80M
8.53M
-3.00M
49.98M
Gain or loss from assets sale
-12.72K
12.72K
-193.19K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer